Two start-ups from Memphis and one from Nashville have been selected as finalists for the annual “Life Science Venture Forum” held during “LSTCON,” Life Science Tennessee’s annual conference. The competition, sponsored by Waller Lansden Dortch & Davis, features a $5,000 prize for the winner.
The finalists are:
- Ichor Sciences, a Nashville-based company that has developed the StatBond, a hemostatic device built to provide both a localized sealant to prevent blood loss and a physical scaffold the body can use to build a clot.
- MiCare Path, one of the two Memphis competitors that seeks to enable Patient Coordinators within physicians’ offices to provide patient monitoring and personalized care pathways in a simple patient app and web platform.
- Diatech Diabetes, the other Memphis company, is developing a patent-pending smart infusion set that monitors and alerts patients with insulin-dependent diabetes and their caretakers of insulin pump delivery malfunctions.
The competition occurs at the end of the second day of the conference on October 28.